Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21967104 | 1.00 | PTGS1 (0.32) | PTGS1PPARAFFAR1ALDH1A1MAPT | |
| SCHEMBL21670650 | 1.00 | PTGS1 (0.32) | PTGS1PPARAFFAR1ALDH1A1MAPT | |
| SCHEMBL30354445 | 1.00 | PTGS1 (0.32) | PTGS1PPARAFFAR1ALDH1A1MAPT | |
| SCHEMBL868995 | 0.80 | — | — | |
| SCHEMBL3366704 | 0.80 | — | — | |
| SCHEMBL21670643 | 0.79 | THRB (0.32) | PTGS1ALDH1A1 | |
| SCHEMBL3504051 | 0.79 | THRB (0.32) | PTGS1ALDH1A1 | |
| SCHEMBL21967082 | 0.79 | THRB (0.32) | PTGS1ALDH1A1 | |
| SCHEMBL21670606 | 0.79 | THRB (0.32) | PTGS1ALDH1A1 | |
| SCHEMBL5815237 | 0.76 | MEN1 (0.38) | PTGS1ALDH1A1MAPTPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110551009-B | Process for the preparation of (2E, 6Z) -2, 6-nonenal and (2E) -cis-6, 7-epoxy-2-nonenal | 信越化学工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| EP-3608302-B1 | PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2021-10-20 | — | — | EP | disclosed |
| US-10781146-B2 | Process for preparing a 5-alken-1-yne compound, (6Z)-1,1-dialkoxy-6-nonen-2-yne compound, (2E,6Z)-2,6-nonadienal and (2E)-cis-6,7-epoxy-2-nonenal, and 1,1-dialkoxy-6-nonen-2-yne compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-09-22 | — | — | US | disclosed |
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-26 | — | — | US | disclosed |
| CN-110818523-A | Process for preparing 5-en-1-ynes and their derivatives and 1, 1-dialkoxy-6-nonene-2-ynes | 信越化学工业株式会社 | 2020-02-21 | — | — | CN | disclosed |
| US-20200048161-A1 | PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
| EP-3608302-A1 | PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-02-12 | — | — | EP | disclosed |
| CN-110551009-A | Process for the preparation of (2E,6Z) -2, 6-nonadienal and (2E) -cis-6, 7-epoxy-2-nonenal | SHINETSU CHEMICAL CO | 2019-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10781146-B2 | Process for preparing a 5-alken-1-yne compound, (6Z)-1,1-dialkoxy-6-nonen-2-yne compound, (2E,6Z)-2,6-nonadienal and (2E)-cis-6,7-epoxy-2-nonenal, and 1,1-dialkoxy-6-nonen-2-yne compound | CBR1, CBR3, DECR1 | PTGS1 2115/4885PPARA 4618/4885FFAR1 243/4885 |
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | CYP2E1, CYP2A6, CYP2J2 | PTGS1 205/4885PPARA 2252/4885FFAR1 1084/4885 |
| US-20200048161-A1 | PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND | CBR1, CBR3, DECR1 | PTGS1 2324/4885PPARA 4647/4885FFAR1 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.